全球空间基因组学市场 – 行业趋势和 2030 年预测

 空间基因组学市场分析和规模

乳腺癌是世界上最常见的癌症之一。根据 2020 年 1 月发表的一项研究，乳腺癌是女性所有癌症中发病率最高的。该研究还指出，乳腺癌的年发病率超过 160 万例。这就需要使用早期诊断程序，而这正是特定基因组学发挥作用的地方。

Data Bridge Market Research 分析，空间基因组学市场在 2022 年为 2.0401 亿美元，预计到 2030 年将达到 4.9086 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 11.6%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

空间基因组学市场范围和细分  

Market Definition

Spatial genomics is the study of the entire set of genetic commands provided by DNA to detect and diagnose cancer tumour cells. Spatial genomics is used in disease control because it provides quantitative gene expression data. Spatial genomics also provides information on visualizing DNA and RNA mapping into tissue components.

Spatial Genomics Market Dynamics

Drivers

• Rising applications of genomics

The increasing use of genomics and transcriptomics by academic institute researchers is one factor driving market growth. These techniques are widely used for the comprehensive evaluation of a wide range of diseases. For instance, a research institute like Children's Hospital for Philadelphia has experience in both locus discovery and GWAS in both academic and biotech settings. These have established a longitudinal and functional genomics centre to study the genetics of various diseases and the morphology of diseases resulting from genetic disorders such as cancer, diabetes, and Alzheimer's. Furthermore, genomic and transcriptomics technology has broader applications in the sector, such as the Human Cell Atlas. These are the certain factors which propel the market.

• Increasing consumable adoption

Consumable's is significantly boosting the spatial genomics and transcriptomics market in the forecast period with a market share of 57.2% in 2021. The market's expansion is attributed to factors such as high product penetration, increasing consumable adoption, frequent use of kits and reagents for instruments in genomics and transcriptomics, and the wide availability of consumables. These instruments are used to prepare sample specimens for genomic mapping. Furthermore, advancements and new features in the consumables segment are increasing the adoption of biopharmaceuticals and research activities.

Opportunities

• Rising adoption of the transcriptomics

The high adoption of the transcriptomics for single-cell transcriptomics analysis compared to the genomics segment is attributed to the segment's growth. The availability of automated sequencing methods such as laser capture microdissection technique (LCM) to satisfy the requirement for nucleic acid sequencing of biological specimens has accelerated the growth of the spatial genomics market. Furthermore, increased awareness of tissue heterogeneity has fuelled the development of novel sequencing technologies aimed at storing genomic or spatial information for future reference. And it is likely that this factor will propel the market growth during the forecast period.

Restraints/Challenges

• High costs associated with R&D capabilities

High costs associated with R&D capabilities, limited infrastructural facilities, uneven distribution of medical services, a scarcity of skilled medical professionals, and a lack of awareness in backward economies are expected to hamper the market growth. In addition, a lack of favourable reimbursement scenarios and technological penetration in developing economies, the emergence of alternative technologies, limited insurance coverage and regulatory compliance, and a lack of suitable infrastructure in low- and middle-income countries are expected to pose challenges to the market during the forecast period of 2023-2030.

This spatial genomics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spatial genomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Spatial Genomics Market

The COVID-19 pandemic had a significant impact on the market. This is because the majority of healthcare resources were directed toward meeting the demand generated by COVID-19 patients. The postponement of non-elective surgeries and non-essential healthcare procedures has slowed the market's growth rate during this pandemic. Shutdown of research facilities and a halt on the projects of pharmaceutical and biotechnological industries also derailed the market growth rate. Furthermore, travel restrictions imposed by lockdown regulations hampered market growth during this period. The post-pandemic period, on the other hand, will help to generate profits and revenues due to an increase in the use of spatial genomics and transcriptomics to profile COVID-19 tissue autopsies, as well as an increase in biomarker identification.

Recent Developments

• 2020 年，基于 NanoString Technologies 的 GeoMx 数字空间分析器 (DSP) 平台的新产品 Cancer Transcriptome Atlas 上市，该产品针对 Illumina 的下一代测序 (NGS) 技术读取进行了优化。
• 2020 年，S2 Genomics 推出了 Singulator 100 系统，该系统可自动将固体组织样本处理成高产量的单细胞或细胞核悬浮液，并从小样本中处理出各种单细胞生物学和基因组分析。

全球空间基因组学市场范围

空间基因组学市场根据技术、最终用户、产品和应用进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

技术

• 荧光原位杂交（FISH）
• 基于显微镜的活体DNA成像
• 基因组扰动工具
• 大规模平行测序
• 生化技术
• 其他的

产品

• 仪器
• 耗材
• 软件

终端用户

• 转化研究
• 学术客户
• 诊断客户
• 制药商
• 政府机构和学术中心
• 制药和生物技术公司
• 合同研究组织

应用

• 诊断和疾病分析
• 药物研发
• 其他的

空间基因组学市场区域分析/见解

对空间基因组学市场进行了分析，并按国家、技术、最终用户、产品和应用提供了市场规模洞察和趋势。

空间基因组学市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的亚太地区其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。

北美在空间基因组学市场占据主导地位，因为该地区拥有强大的医疗设施基础、药物的广泛使用、生活方式疾病的发病率不断增加、对保持身体健康本质的意识不断增强以及研究活动数量不断增加。

预计亚太地区将在 2023 年至 2030 年的预测期内以最高的增长率增长，原因是政府加大了提高认识的力度、医疗旅游业兴起、该地区的研究活动日益增多、有大量未开发的市场、生活方式疾病发病率不断上升、人口规模庞大以及对优质医疗服务的需求不断增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和空间基因组学市场份额分析

空间基因组学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对空间基因组学市场的关注有关。

空间基因组学市场的一些主要参与者包括：

• 赛默飞世尔科技公司（美国）
• 10X Genomics（美国）
• NanoString Technologies Inc.（美国）
• Illumina Inc.（美国）
• Bio-Rad Laboratories, Inc.（美国）
• QIAGEN（荷兰）
• 安捷伦科技公司（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• S2 Genomics, Inc.（美国）
• Seven Bridges Genomics（美国）
• CARTANA AB（瑞典）
• READCOOR, INC（美国）
• Advanced Cell Diagnostics, Inc.（美国）
• Dovetail Genomics（美国）
• 诺华公司（瑞士）
• 辉瑞公司（美国）
• 默克公司（德国）
• 诺和诺德公司（丹麦）
• 安进公司 (美国)
• 强生服务公司（美国）
• 葛兰素史克公司 (英国)
• 拜耳公司（德国）   

SKU-52700